{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:20:08Z","timestamp":1791076808672,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":1929,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To investigate the clinical effect of SR49059 when given shortly before the onset of menstruation as a preventative treatment of dysmenorrhoea.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> A double\u2010blind, randomised, placebo\u2010controlled, cross\u2010over trial in complete block design (three periods, three treatments).<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> A clinical research organisation in Paris, France.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Women aged 18\u201335 years suffering from primary dysmenorrhoea.<\/jats:p><jats:p><jats:bold>Interventions\n\t\t\t\t\t<\/jats:bold> In each of three menstrual cycles, women reported to the study centre and were given a daily dose of either placebo, 100 mg or 300 mg SR49059 from a minimum of 4 hours up to a maximum of three days before the onset of bleeding and\/or menstrual pain. If this did not control the pain, women were allowed once a day to take a second dose of study treatment providing that at least 4 hours had passed since the first drug intake.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Intensity of menstrual pain recorded by means of a visual analogue scale. Rating of symptoms of dysmenorrhoea (mainly back and pelvic pain) in relation to functional capacity (Sultan score). Self\u2010assessment of menstrual blood loss in a menstrual diary record.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Analysis of intensity of menstrual pain, as recorded by visual analogue scale and Sultan pain score (back and pelvic pain) during the first 24 hours of dysmenorrhoea, showed a dose\u2010related effect of SR49059. The 300 mg dose of SR49059 was significantly more effective than placebo. Similarly, a dose\u2010related effect of SR49059 was shown on total Sultan score. SR49059 was well tolerated and no significant effect on the bleeding pattern was noted.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> This study showed for the first time a therapeutic effect of an orally active vasopressin V<jats:sub>1a<\/jats:sub> receptor antagonist in the prevention of dysmenorrhoea. Further studies are required to examine effect mechanisms and determine effective doses.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2000.tb13302.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:40:49Z","timestamp":1123843249000},"page":"614-619","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Effect of SR49059, an orally active V<sub>1a<\/sub> vasopressin receptor antagonist, in the prevention of dysmenorrhoea"],"prefix":"10.1111","volume":"107","author":[{"given":"R.","family":"Brouard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bossmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fourni\u00e9\u2010Lloret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c5kerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1976.tb00911.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1979.tb10794.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348409156715"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13855.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349109007155"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb10880.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116554"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4871-3_59"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349609054663"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016349808565802"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11500.x"},{"key":"e_1_2_5_13_2","first-page":"149","article-title":"Experimental designs balanced for the residual effects of treatment","volume":"2","author":"William EJ","year":"1949","journal-title":"Aust J Sci Res"},{"key":"e_1_2_5_14_2","first-page":"309","article-title":"Evaluation clinique quantitative de l'action de la dydrogesterone dans la dysm\u00e9norrh\u00e9e de la jeune fille","volume":"36","author":"Sultan C","year":"1985","journal-title":"Gyn\u00e9cologie"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb16249.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348709022055"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348509156728"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08112.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.5.1121"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2000.tb13302.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2000.tb13302.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T06:57:37Z","timestamp":1698562657000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2000.tb13302.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1111\/j.1471-0528.2000.tb13302.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13302.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"2005-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}